RIMI - Repository of the Institute for Medical Research
Institute for Medical Research
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   RIMI
  • Institut za medicinska istraživanja
  • Radovi istraživača / Researchers' publications
  • View Item
  •   RIMI
  • Institut za medicinska istraživanja
  • Radovi istraživača / Researchers' publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Treatment outcome of HAART-treated patients in a resource-limited setting: The Belgrade Cohort Study

Authorized Users Only
2014
Authors
Jevtović, Đorđe
Dragović, Gordana
Salemović, Dubravka
Ranin, Jovan
Kusić, Jovana
Marinković, Jelena
Đurković-Đaković, Olgica
Article (Published version)
Metadata
Show full item record
Abstract
Introduction: We evaluated the effects of highly-active-antiretroviral-therapy (HAART) in a resource-limited settings. Methods: A cross-sectional study was performed in patients who had initiated HAART at the HIV/AIDS-Center, Belgrade, Serbia. Treatment response was considered favorable in case of the achievement of undetectable HIVRNA plasma-viral-load (pVL lt 50 copies/mu L), and with the CD4+ T-cell counts increased above 350 cells/mu L. The treatment failure was defined as pVL over 1.7 log(10) copies/mL, regardless of immunological improvement. Results: Eight hundred and forty HIV infected patients were followed-up for 8.2 +/- 3.4 years. Out of 697 patients available for follow-up, 113 (16.2%) patients died, 44 (6.3%) experienced treatment failure, while 540 (77.5%) had sustained undetectable viremia. In 419 (60.1%) favorable treatment response was achieved, while the dissociation between immunological and virological responses to HAART occurred in 121 (14.4%). A baseline CD4+ T-...cell counts above 200 cells/mL was the single independent predictor of a favorable treatment response (HR = 2, 95%CI = 1.69-2.61, P = 0.001), while pre-treatment with ART, HCV co-infection and AIDS at the time of treatment initiation, were all factors preventing a favorable response (HR = 0.27, 95% CI = 0.19-0.36, P = 0.001; HR = 0.75, 95% CI = 0.56-0.95, P = 0.02; HR = 0.73, 95% CI = 0.17-0.95, P = 0.018, respectively). A sustained viral suppression was an independent predictor of survival (HR = 0.2, 95% CI 0.07-0.61, P = 0.004). HAART treated HIV-infected patients who reach and maintain undetectable viremia, have an 80% probability of a 14-years survival (P = 0.08, log-rank). Conclusion: If patient with advanced HIV-related immunodeficiency reach and maintain optimal viral suppression during HAART, regardless of the level of immune recovery, and if they continue to maintain this, their prognosis may be fairly good even in the resource-limited settings.

Keywords:
HIV / HAART / Survival / Resource limited settings
Source:
Biomedicine & Pharmacotherapy, 2014, 68, 3, 391-395
Publisher:
  • Elsevier France-Editions Scientifiques Medicales Elsevier, Issy-Les-Moulineaux
Funding / projects:
  • Control of infections by Apicomplexan pathogens: from novel drug targets to prediction (RS-41019)
  • Phylogenetic anaysis and molecular evolution of highly variable viruses: coinfections, host-pathogene interactions (RS-175024)

DOI: 10.1016/j.biopha.2014.01.001

ISSN: 0753-3322

PubMed: 24486106

WoS: 000335395400020

Scopus: 2-s2.0-84899485368
[ Google Scholar ]
6
6
URI
http://rimi.imi.bg.ac.rs/handle/123456789/589
Collections
  • Radovi istraživača / Researchers' publications
Institution/Community
Institut za medicinska istraživanja
TY  - JOUR
AU  - Jevtović, Đorđe
AU  - Dragović, Gordana
AU  - Salemović, Dubravka
AU  - Ranin, Jovan
AU  - Kusić, Jovana
AU  - Marinković, Jelena
AU  - Đurković-Đaković, Olgica
PY  - 2014
UR  - http://rimi.imi.bg.ac.rs/handle/123456789/589
AB  - Introduction: We evaluated the effects of highly-active-antiretroviral-therapy (HAART) in a resource-limited settings. Methods: A cross-sectional study was performed in patients who had initiated HAART at the HIV/AIDS-Center, Belgrade, Serbia. Treatment response was considered favorable in case of the achievement of undetectable HIVRNA plasma-viral-load (pVL  lt  50 copies/mu L), and with the CD4+ T-cell counts increased above 350 cells/mu L. The treatment failure was defined as pVL over 1.7 log(10) copies/mL, regardless of immunological improvement. Results: Eight hundred and forty HIV infected patients were followed-up for 8.2 +/- 3.4 years. Out of 697 patients available for follow-up, 113 (16.2%) patients died, 44 (6.3%) experienced treatment failure, while 540 (77.5%) had sustained undetectable viremia. In 419 (60.1%) favorable treatment response was achieved, while the dissociation between immunological and virological responses to HAART occurred in 121 (14.4%). A baseline CD4+ T-cell counts above 200 cells/mL was the single independent predictor of a favorable treatment response (HR = 2, 95%CI = 1.69-2.61, P = 0.001), while pre-treatment with ART, HCV co-infection and AIDS at the time of treatment initiation, were all factors preventing a favorable response (HR = 0.27, 95% CI = 0.19-0.36, P = 0.001; HR = 0.75, 95% CI = 0.56-0.95, P = 0.02; HR = 0.73, 95% CI = 0.17-0.95, P = 0.018, respectively). A sustained viral suppression was an independent predictor of survival (HR = 0.2, 95% CI 0.07-0.61, P = 0.004). HAART treated HIV-infected patients who reach and maintain undetectable viremia, have an 80% probability of a 14-years survival (P = 0.08, log-rank). Conclusion: If patient with advanced HIV-related immunodeficiency reach and maintain optimal viral suppression during HAART, regardless of the level of immune recovery, and if they continue to maintain this, their prognosis may be fairly good even in the resource-limited settings.
PB  - Elsevier France-Editions Scientifiques Medicales Elsevier, Issy-Les-Moulineaux
T2  - Biomedicine & Pharmacotherapy
T1  - Treatment outcome of HAART-treated patients in a resource-limited setting: The Belgrade Cohort Study
EP  - 395
IS  - 3
SP  - 391
VL  - 68
DO  - 10.1016/j.biopha.2014.01.001
UR  - conv_3223
ER  - 
@article{
author = "Jevtović, Đorđe and Dragović, Gordana and Salemović, Dubravka and Ranin, Jovan and Kusić, Jovana and Marinković, Jelena and Đurković-Đaković, Olgica",
year = "2014",
abstract = "Introduction: We evaluated the effects of highly-active-antiretroviral-therapy (HAART) in a resource-limited settings. Methods: A cross-sectional study was performed in patients who had initiated HAART at the HIV/AIDS-Center, Belgrade, Serbia. Treatment response was considered favorable in case of the achievement of undetectable HIVRNA plasma-viral-load (pVL  lt  50 copies/mu L), and with the CD4+ T-cell counts increased above 350 cells/mu L. The treatment failure was defined as pVL over 1.7 log(10) copies/mL, regardless of immunological improvement. Results: Eight hundred and forty HIV infected patients were followed-up for 8.2 +/- 3.4 years. Out of 697 patients available for follow-up, 113 (16.2%) patients died, 44 (6.3%) experienced treatment failure, while 540 (77.5%) had sustained undetectable viremia. In 419 (60.1%) favorable treatment response was achieved, while the dissociation between immunological and virological responses to HAART occurred in 121 (14.4%). A baseline CD4+ T-cell counts above 200 cells/mL was the single independent predictor of a favorable treatment response (HR = 2, 95%CI = 1.69-2.61, P = 0.001), while pre-treatment with ART, HCV co-infection and AIDS at the time of treatment initiation, were all factors preventing a favorable response (HR = 0.27, 95% CI = 0.19-0.36, P = 0.001; HR = 0.75, 95% CI = 0.56-0.95, P = 0.02; HR = 0.73, 95% CI = 0.17-0.95, P = 0.018, respectively). A sustained viral suppression was an independent predictor of survival (HR = 0.2, 95% CI 0.07-0.61, P = 0.004). HAART treated HIV-infected patients who reach and maintain undetectable viremia, have an 80% probability of a 14-years survival (P = 0.08, log-rank). Conclusion: If patient with advanced HIV-related immunodeficiency reach and maintain optimal viral suppression during HAART, regardless of the level of immune recovery, and if they continue to maintain this, their prognosis may be fairly good even in the resource-limited settings.",
publisher = "Elsevier France-Editions Scientifiques Medicales Elsevier, Issy-Les-Moulineaux",
journal = "Biomedicine & Pharmacotherapy",
title = "Treatment outcome of HAART-treated patients in a resource-limited setting: The Belgrade Cohort Study",
pages = "395-391",
number = "3",
volume = "68",
doi = "10.1016/j.biopha.2014.01.001",
url = "conv_3223"
}
Jevtović, Đ., Dragović, G., Salemović, D., Ranin, J., Kusić, J., Marinković, J.,& Đurković-Đaković, O.. (2014). Treatment outcome of HAART-treated patients in a resource-limited setting: The Belgrade Cohort Study. in Biomedicine & Pharmacotherapy
Elsevier France-Editions Scientifiques Medicales Elsevier, Issy-Les-Moulineaux., 68(3), 391-395.
https://doi.org/10.1016/j.biopha.2014.01.001
conv_3223
Jevtović Đ, Dragović G, Salemović D, Ranin J, Kusić J, Marinković J, Đurković-Đaković O. Treatment outcome of HAART-treated patients in a resource-limited setting: The Belgrade Cohort Study. in Biomedicine & Pharmacotherapy. 2014;68(3):391-395.
doi:10.1016/j.biopha.2014.01.001
conv_3223 .
Jevtović, Đorđe, Dragović, Gordana, Salemović, Dubravka, Ranin, Jovan, Kusić, Jovana, Marinković, Jelena, Đurković-Đaković, Olgica, "Treatment outcome of HAART-treated patients in a resource-limited setting: The Belgrade Cohort Study" in Biomedicine & Pharmacotherapy, 68, no. 3 (2014):391-395,
https://doi.org/10.1016/j.biopha.2014.01.001 .,
conv_3223 .

DSpace software copyright © 2002-2015  DuraSpace
About RIMI | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About RIMI | Send Feedback

OpenAIRERCUB